108 related articles for article (PubMed ID: 35657733)
1. Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma.
Cui H; Zhang L; Zeng S; Wang Y; Li Z; Wang J; Chen Q
ACS Appl Mater Interfaces; 2022 Jul; 14(27):30493-30506. PubMed ID: 35657733
[TBL] [Abstract][Full Text] [Related]
2. Reversible Chemical Protein Modification to Endogenous Glutathione and Its Utilities in the Manufacture of Transcellular Pro-Enzymes.
Wang Y; Zeng S; Cui H; Li H; Li Z; Wang J; Chen Q
Biomacromolecules; 2022 May; 23(5):2138-2149. PubMed ID: 35471918
[TBL] [Abstract][Full Text] [Related]
3. pH-responsive organic/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy.
Cui H; Zhang M; Zhang L; Li H; Wang Y; Zhao Y; Chen Q; Wang J
J Colloid Interface Sci; 2023 Mar; 634():388-401. PubMed ID: 36542969
[TBL] [Abstract][Full Text] [Related]
4. Virus-like siRNA construct dynamically responsive to sequential microenvironments for potent RNA interference.
Wang Y; Zheng X; Liu J; Chen L; Chen Q; Zhao Y
J Colloid Interface Sci; 2022 Sep; 622():938-949. PubMed ID: 35561612
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Targeted Anti-VEGF RNAi Capable of Sequentially Responding to Intracellular Microenvironments for Potent Systemic Tumor Suppression.
Wang Y; Zheng X; Liu J; Chen Q; Zhao Y
ACS Appl Bio Mater; 2020 Dec; 3(12):9145-9155. PubMed ID: 35019592
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin Nanoprodrug Possessing Dual Responsiveness to Endolysosomal pH and Cytosolic Redox for Amplified Cytotoxic Potency.
Chen Q; Sui X; Zhang L; Zhang Q; Han X; Su X; Cui H; Qian M; Zeng S; Wang J
ACS Appl Bio Mater; 2021 Jun; 4(6):4990-4998. PubMed ID: 35007047
[TBL] [Abstract][Full Text] [Related]
7. Synthetic genomic nanomedicine with triple-responsiveness for systemic anti-tumor therapy.
Qin C; Wang H; Cui H; Wang Y; Zhang M; Li H; Liu Y; Wang J; Chen Q; Zhao Y
J Colloid Interface Sci; 2024 Jun; 672():350-362. PubMed ID: 38850862
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic PEG-Poly(amine-co-disulfide ester) Nanoparticles as pH- and Redox-Responsive Drug Nanocarriers for Efficient Antitumor Treatment.
Chen Y; Su M; Li Y; Gao J; Zhang C; Cao Z; Zhou J; Liu J; Jiang Z
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30519-30535. PubMed ID: 28819967
[TBL] [Abstract][Full Text] [Related]
10. Dual environment-responsive polyplex carriers for enhanced intracellular delivery of plasmid DNA.
Sanjoh M; Miyata K; Christie RJ; Ishii T; Maeda Y; Pittella F; Hiki S; Nishiyama N; Kataoka K
Biomacromolecules; 2012 Nov; 13(11):3641-9. PubMed ID: 22994314
[TBL] [Abstract][Full Text] [Related]
11. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression.
Miyata K; Kakizawa Y; Nishiyama N; Harada A; Yamasaki Y; Koyama H; Kataoka K
J Am Chem Soc; 2004 Mar; 126(8):2355-61. PubMed ID: 14982439
[TBL] [Abstract][Full Text] [Related]
12. Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles.
Gou J; Liang Y; Miao L; Guo W; Chao Y; He H; Zhang Y; Yang J; Wu C; Yin T; Wang Y; Tang X
Acta Biomater; 2017 Oct; 62():157-166. PubMed ID: 28827183
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
Chen M; Zhang Y; Chen Z; Xie S; Luo X; Li X
Acta Biomater; 2017 Feb; 49():444-455. PubMed ID: 27940163
[TBL] [Abstract][Full Text] [Related]
14. A Targeted and Stable Polymeric Nanoformulation Enhances Systemic Delivery of mRNA to Tumors.
Chen Q; Qi R; Chen X; Yang X; Wu S; Xiao H; Dong W
Mol Ther; 2017 Jan; 25(1):92-101. PubMed ID: 28129133
[TBL] [Abstract][Full Text] [Related]
15. A pH-responsive drug nanovehicle constructed by reversible attachment of cholesterol to PEGylated poly(l-lysine) via catechol-boronic acid ester formation.
Yang B; Lv Y; Zhu JY; Han YT; Jia HZ; Chen WH; Feng J; Zhang XZ; Zhuo RX
Acta Biomater; 2014 Aug; 10(8):3686-95. PubMed ID: 24879311
[TBL] [Abstract][Full Text] [Related]
16. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
[TBL] [Abstract][Full Text] [Related]
17. pH-Responsive Core-Shell Structured Nanoparticles for Triple-Stage Targeted Delivery of Doxorubicin to Tumors.
Han L; Tang C; Yin C
ACS Appl Mater Interfaces; 2016 Sep; 8(36):23498-508. PubMed ID: 27558413
[TBL] [Abstract][Full Text] [Related]
18. Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration.
Wang J; Shi X; Bo Q; Wang H; Wei F; Liu J; Wang H; Zhang L; Qi Y; Li Z; Chen Q; Sun X
Asian J Pharm Sci; 2021 Sep; 16(5):623-632. PubMed ID: 34849167
[TBL] [Abstract][Full Text] [Related]
19. Precise tuning of disulphide crosslinking in mRNA polyplex micelles for optimising extracellular and intracellular nuclease tolerability.
Dirisala A; Uchida S; Tockary TA; Yoshinaga N; Li J; Osawa S; Gorantla L; Fukushima S; Osada K; Kataoka K
J Drug Target; 2019; 27(5-6):670-680. PubMed ID: 30499743
[TBL] [Abstract][Full Text] [Related]
20. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
